Glenmede Trust CO Na Ultragenyx Pharmaceutical Inc. Transaction History

Glenmede Trust CO Na

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$92.19 - $115.71 $330,777 - $415,167	-3,588 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$106.9 - $167.73 $4,596 - $7,212	43 Added 1.21%	3,588 $408,000
Q4 2020 Feb 16, 2021	BUY	$84.4 - $177.39 $31,312 - $65,811	371 Added 11.69%	3,545 $490,000
Q3 2020 Nov 16, 2020	BUY	$72.98 - $90.0 $230,616 - $284,400	3,160 Added 22571.43%	3,174 $260,000
Q4 2018 Feb 14, 2019	BUY	$38.89 - $77.3 $544 - $1,082	14 New	14 $0

329

85.9M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.18B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.